<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Fine needle <z:hpo ids='HP_0002835'>aspiration</z:hpo> (FNA) cytology is an accepted means of diagnosing and typing common forms of <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, particularly small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, its usefulness for diagnosing less common forms of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is not clearly established and this study was designed to examine this </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The study reviewed the FNAs of suspected <z:hpo ids='HP_0002665'>lymphomas</z:hpo> collected over a period of approximately five years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: FNA samples were available for 138 definite <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; most were common forms of B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, there was also one Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), two Burkitt-like large B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 15 classic Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HLs</z:e>), two nodular lymphocyte predominant Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, four mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, two mediastinal (thymic) large B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (MLBCLs), 11 peripheral T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCLs</z:e>), and five T cell rich large B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (TCRLBCLs) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: FNA diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> was possible with immunoflow cytometry (IFC), cell block immunohistochemistry (IHC), and cell block fluorescent in situ hybridisation for c-myc alteration </plain></SENT>
<SENT sid="6" pm="."><plain>It was difficult to make a definite diagnosis of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> and MLBCL on FNA alone </plain></SENT>
<SENT sid="7" pm="."><plain>Both tend to be sclerotic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and FNA tends to yield scanty neoplastic cells </plain></SENT>
<SENT sid="8" pm="."><plain>The FNA diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e> depended on cell block IHC; IFC was not usually useful </plain></SENT>
<SENT sid="9" pm="."><plain>TCRLBCL did not show light chain restriction on IFC of FNA samples, probably because of frequent reactive B cells in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, MLBCL, and TCRLBCL are often difficult to diagnose accurately on FNA cytology, even when using IFC and cell block IHC </plain></SENT>
</text></document>